LINC02361: A Potential Drug Target and Biomarker (G100996246)

Target Name: LINC02361

NCBI ID: G100996246

Other Name(s): Long intergenic non-protein coding RNA 2361 | long intergenic non-protein coding RNA 2361

LINC02361: A Potential Drug Target and Biomarker

LINC02361 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the cell cycle and is involved in the development, maintenance, and progression of various diseases, including cancer. LINC02361 has been shown to play a critical role in the regulation of cell proliferation, apoptosis, and angiogenesis, which are important processes that are associated with the development and progression of many diseases.

The discovery of LINC02361 as a potential drug target and biomarker has significant implications for the development of new treatments for a variety of diseases. LINC02361 has been shown to be involved in the regulation of cell cycle progression, which is a critical process that is involved in the development and progression of cancer. It has also been shown to be involved in the regulation of apoptosis, which is the process by which cells undergo programmed cell death.

Apoptosis is a natural process that is important for the development and progression of many diseases, including cancer. It is a critical process that helps to remove damaged or dysfunctional cells from the body, which is essential for maintaining the health and function of the body. However, in the case of cancer, apoptosis can become aberrant and lead to the continued growth and progression of the disease.

LINC02361 has been shown to play a critical role in the regulation of apoptosis. It has been shown to promote the execution of programmed cell death, which is critical for the regulation of cell cycle progression and the development and progression of cancer. LINC02361 has also been shown to regulate the clearance of damaged cells from the body, which is important for the regulation of apoptosis.

In addition to its role in apoptosis, LINC02361 has also been shown to play a critical role in the regulation of cell cycle progression. It has been shown to promote the growth and proliferation of cells, which is important for the development and progression of many diseases, including cancer. LINC02361 has also been shown to regulate the expression of genes that are involved in cell cycle progression, which is important for the development and progression of cancer.

The potential utility of LINC02361 as a drug target and biomarker is significant. By targeting LINC02361 with drugs, it is possible to inhibit its activity and prevent the development and progression of many diseases, including cancer. Additionally, LINC02361 can also be used as a biomarker to diagnose and monitor the progress of diseases.

In conclusion, LINC02361 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its role in the regulation of cell cycle progression and apoptosis makes it an attractive target for the development of new treatments for a variety of diseases, including cancer. Further research is needed to fully understand the potential utility of LINC02361 as a drug and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2361

More Common Targets